Copyright Reports & Markets. All rights reserved.

Global Fibroblast Growth Factor Receptor 4 Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Fibroblast Growth Factor Receptor 4

      • 1.1 Definition of Fibroblast Growth Factor Receptor 4
      • 1.2 Fibroblast Growth Factor Receptor 4 Segment by Type
        • 1.2.1 Global Fibroblast Growth Factor Receptor 4 Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 BLU-9931
        • 1.2.3 BMS-986036
        • 1.2.4 Erdafitinib
        • 1.2.5 ES-135
        • 1.2.6 FGF-401
        • 1.2.7 Others
      • 1.3 Fibroblast Growth Factor Receptor 4 Segment by Applications
        • 1.3.1 Global Fibroblast Growth Factor Receptor 4 Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Breast Cancer
        • 1.3.3 Lymphoma
        • 1.3.4 Melanoma
        • 1.3.5 Fallopian Tube Cancer
        • 1.3.6 Lung Cancer
        • 1.3.7 Others
      • 1.4 Global Fibroblast Growth Factor Receptor 4 Overall Market
        • 1.4.1 Global Fibroblast Growth Factor Receptor 4 Revenue (2014-2025)
        • 1.4.2 Global Fibroblast Growth Factor Receptor 4 Production (2014-2025)
        • 1.4.3 North America Fibroblast Growth Factor Receptor 4 Status and Prospect (2014-2025)
        • 1.4.4 Europe Fibroblast Growth Factor Receptor 4 Status and Prospect (2014-2025)
        • 1.4.5 China Fibroblast Growth Factor Receptor 4 Status and Prospect (2014-2025)
        • 1.4.6 Japan Fibroblast Growth Factor Receptor 4 Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Fibroblast Growth Factor Receptor 4 Status and Prospect (2014-2025)
        • 1.4.8 India Fibroblast Growth Factor Receptor 4 Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Fibroblast Growth Factor Receptor 4
      • 2.3 Manufacturing Process Analysis of Fibroblast Growth Factor Receptor 4
      • 2.4 Industry Chain Structure of Fibroblast Growth Factor Receptor 4

      3 Development and Manufacturing Plants Analysis of Fibroblast Growth Factor Receptor 4

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Fibroblast Growth Factor Receptor 4 Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Fibroblast Growth Factor Receptor 4
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Fibroblast Growth Factor Receptor 4 Production and Capacity Analysis
      • 4.2 Fibroblast Growth Factor Receptor 4 Revenue Analysis
      • 4.3 Fibroblast Growth Factor Receptor 4 Price Analysis
      • 4.4 Market Concentration Degree

      5 Fibroblast Growth Factor Receptor 4 Regional Market Analysis

      • 5.1 Fibroblast Growth Factor Receptor 4 Production by Regions
        • 5.1.1 Global Fibroblast Growth Factor Receptor 4 Production by Regions
        • 5.1.2 Global Fibroblast Growth Factor Receptor 4 Revenue by Regions
      • 5.2 Fibroblast Growth Factor Receptor 4 Consumption by Regions
      • 5.3 North America Fibroblast Growth Factor Receptor 4 Market Analysis
        • 5.3.1 North America Fibroblast Growth Factor Receptor 4 Production
        • 5.3.2 North America Fibroblast Growth Factor Receptor 4 Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Fibroblast Growth Factor Receptor 4 Import and Export
      • 5.4 Europe Fibroblast Growth Factor Receptor 4 Market Analysis
        • 5.4.1 Europe Fibroblast Growth Factor Receptor 4 Production
        • 5.4.2 Europe Fibroblast Growth Factor Receptor 4 Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Fibroblast Growth Factor Receptor 4 Import and Export
      • 5.5 China Fibroblast Growth Factor Receptor 4 Market Analysis
        • 5.5.1 China Fibroblast Growth Factor Receptor 4 Production
        • 5.5.2 China Fibroblast Growth Factor Receptor 4 Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Fibroblast Growth Factor Receptor 4 Import and Export
      • 5.6 Japan Fibroblast Growth Factor Receptor 4 Market Analysis
        • 5.6.1 Japan Fibroblast Growth Factor Receptor 4 Production
        • 5.6.2 Japan Fibroblast Growth Factor Receptor 4 Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Fibroblast Growth Factor Receptor 4 Import and Export
      • 5.7 Southeast Asia Fibroblast Growth Factor Receptor 4 Market Analysis
        • 5.7.1 Southeast Asia Fibroblast Growth Factor Receptor 4 Production
        • 5.7.2 Southeast Asia Fibroblast Growth Factor Receptor 4 Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Fibroblast Growth Factor Receptor 4 Import and Export
      • 5.8 India Fibroblast Growth Factor Receptor 4 Market Analysis
        • 5.8.1 India Fibroblast Growth Factor Receptor 4 Production
        • 5.8.2 India Fibroblast Growth Factor Receptor 4 Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Fibroblast Growth Factor Receptor 4 Import and Export

      6 Fibroblast Growth Factor Receptor 4 Segment Market Analysis (by Type)

      • 6.1 Global Fibroblast Growth Factor Receptor 4 Production by Type
      • 6.2 Global Fibroblast Growth Factor Receptor 4 Revenue by Type
      • 6.3 Fibroblast Growth Factor Receptor 4 Price by Type

      7 Fibroblast Growth Factor Receptor 4 Segment Market Analysis (by Application)

      • 7.1 Global Fibroblast Growth Factor Receptor 4 Consumption by Application
      • 7.2 Global Fibroblast Growth Factor Receptor 4 Consumption Market Share by Application (2014-2019)

      8 Fibroblast Growth Factor Receptor 4 Major Manufacturers Analysis

      • 8.1 Amgen Inc
        • 8.1.1 Amgen Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
        • 8.1.2 Amgen Inc Product Introduction, Application and Specification
        • 8.1.3 Amgen Inc Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 ArQule Inc
        • 8.2.1 ArQule Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
        • 8.2.2 ArQule Inc Product Introduction, Application and Specification
        • 8.2.3 ArQule Inc Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 AstraZeneca Plc
        • 8.3.1 AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
        • 8.3.2 AstraZeneca Plc Product Introduction, Application and Specification
        • 8.3.3 AstraZeneca Plc Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Blueprint Medicines Corp
        • 8.4.1 Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
        • 8.4.2 Blueprint Medicines Corp Product Introduction, Application and Specification
        • 8.4.3 Blueprint Medicines Corp Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Bristol-Myers Squibb Co
        • 8.5.1 Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
        • 8.5.2 Bristol-Myers Squibb Co Product Introduction, Application and Specification
        • 8.5.3 Bristol-Myers Squibb Co Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Eisai Co Ltd
        • 8.6.1 Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
        • 8.6.2 Eisai Co Ltd Product Introduction, Application and Specification
        • 8.6.3 Eisai Co Ltd Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Eli Lilly and Co
        • 8.7.1 Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
        • 8.7.2 Eli Lilly and Co Product Introduction, Application and Specification
        • 8.7.3 Eli Lilly and Co Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Genosco Inc
        • 8.8.1 Genosco Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
        • 8.8.2 Genosco Inc Product Introduction, Application and Specification
        • 8.8.3 Genosco Inc Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 H3 Biomedicine Inc
        • 8.9.1 H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
        • 8.9.2 H3 Biomedicine Inc Product Introduction, Application and Specification
        • 8.9.3 H3 Biomedicine Inc Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Incyte Corp
        • 8.10.1 Incyte Corp Fibroblast Growth Factor Receptor 4 Production Sites and Area Served
        • 8.10.2 Incyte Corp Product Introduction, Application and Specification
        • 8.10.3 Incyte Corp Fibroblast Growth Factor Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Ionis Pharmaceuticals Inc
      • 8.12 Johnson & Johnson
      • 8.13 Merrimack Pharmaceuticals Inc
      • 8.14 NGM Biopharmaceuticals Inc
      • 8.15 Novartis AG
      • 8.16 Principia Biopharma Inc
      • 8.17 Tasly Pharmaceutical Group Co Ltd
      • 8.18 Vichem Chemie Research Ltd

      9 Development Trend of Analysis of Fibroblast Growth Factor Receptor 4 Market

      • 9.1 Global Fibroblast Growth Factor Receptor 4 Market Trend Analysis
        • 9.1.1 Global Fibroblast Growth Factor Receptor 4 Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Fibroblast Growth Factor Receptor 4 Regional Market Trend
        • 9.2.1 North America Fibroblast Growth Factor Receptor 4 Forecast 2019-2025
        • 9.2.2 Europe Fibroblast Growth Factor Receptor 4 Forecast 2019-2025
        • 9.2.3 China Fibroblast Growth Factor Receptor 4 Forecast 2019-2025
        • 9.2.4 Japan Fibroblast Growth Factor Receptor 4 Forecast 2019-2025
        • 9.2.5 Southeast Asia Fibroblast Growth Factor Receptor 4 Forecast 2019-2025
        • 9.2.6 India Fibroblast Growth Factor Receptor 4 Forecast 2019-2025
      • 9.3 Fibroblast Growth Factor Receptor 4 Market Trend (Product Type)
      • 9.4 Fibroblast Growth Factor Receptor 4 Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Fibroblast Growth Factor Receptor 4 Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Fibroblast Growth Factor Receptor 4 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Fibroblast Growth Factor Receptor 4 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fibroblast Growth Factor Receptor 4 market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Fibroblast Growth Factor Receptor 4 in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Fibroblast Growth Factor Receptor 4 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Amgen Inc
        ArQule Inc
        AstraZeneca Plc
        Blueprint Medicines Corp
        Bristol-Myers Squibb Co
        Eisai Co Ltd
        Eli Lilly and Co
        Genosco Inc
        H3 Biomedicine Inc
        Incyte Corp
        Ionis Pharmaceuticals Inc
        Johnson & Johnson
        Merrimack Pharmaceuticals Inc
        NGM Biopharmaceuticals Inc
        Novartis AG
        Principia Biopharma Inc
        Tasly Pharmaceutical Group Co Ltd
        Vichem Chemie Research Ltd

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        BLU-9931
        BMS-986036
        Erdafitinib
        ES-135
        FGF-401
        Others

        Segment by Application
        Breast Cancer
        Lymphoma
        Melanoma
        Fallopian Tube Cancer
        Lung Cancer
        Others

        Buy now